Open AccessTension Pneumomediastinum: A life-threatening condition in patients with COVID-19
Author(s) -
Nissar Shaikh,
Gamal Al Ameri,
Muhsen Shaheen,
Wael I. Abdaljawad,
Sujith Prabhakaran,
Mohammad Al Wraidat,
Ahmed S. Mohmed,
Mohamad Khatib,
Abdulqadir J. Nashwan
Publication year - 2021
Publication title -
qatar medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.171
H-Index - 9
eISSN - 2227-0426
pISSN - 0253-8253
DOI - 10.5339/qmj.2021.55
Subject(s) - medicine , ards , pneumomediastinum , extracorporeal membrane oxygenation , pneumonia , anesthesia , lung , mechanical ventilation , surgery , intensive care medicine , pneumothorax
Tension pneumomediastinum (TPM) is a rare but potentially fatal clinical entity. TPM leads to the leakage of air into the mediastinal cavity and increased pressure in thoracic vessels, respiratory tract, and the heart. Herein, this report presents a series of five cases of coronavirus disease-2019 (COVID-19) that caused acute respiratory distress syndrome (ARDS) and TPM. All patients were male who had severe ARDS with a secondary lung infection that required invasive ventilation and had moderate positive-end expiratory pressure. All patients required vasopressors to maintain hemodynamics, and two patients needed decompression with chest drains. One patient received extracorporeal membrane oxygenation therapy. Three patients had cardiac arrest, and two patients died; thus, the mortality rate was 40%. Patients with COVID-19 pneumonia with ARDS required invasive ventilation and prone positioning. Secondary lung infection can cause TPM, and TPM may cause cardiac arrest. Management should be prompt recognition and decompression with the insertion of drains, and conservative treatment is required in stable cases. Protocols for the management of pneumomediastinum and TPM may enable early detection, earlier management, and prevention of TPM.